Recardio's Positive Phase 2 Results Presented as Latebreaker at World Congress on Acute Heart Failure 2022 in Madrid
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
📰 Latebreaker Session News
Latebreaker Session News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Latebreaker Session. Real-time updates on events, politics, business and more.
Recardio's Phase 2 Results Will Be Presented as Latebreaker at World Congress on Heart Failure 2022
Recardio Inc., a clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the study results of Recardio's Phase 2 clinical study in Acute Myocardial Infarction will be presented on Saturday, May 21, 2022, during the Latebreaker Session at the World Congre...
United States San Francisco Recardio Inc World Congress World Congress On Acute Heart Failure Acute Myocardial Infarction
Source: pharmiweb.com